RCM
DRNA
RA Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,456,669
| Closed | -$35.3M | – | 41 |
|
|
2019
Q3 | $35.3M | Hold |
2,456,669
| – | – | 2.1% | 15 |
|
|
2019
Q2 | $38.7M | Hold |
2,456,669
| – | – | 2.08% | 12 |
|
|
2019
Q1 | $36M | Hold |
2,456,669
| – | – | 1.55% | 19 |
|
|
2018
Q4 | $26.3M | Sell |
2,456,669
-1,476,820
| -38% | -$15.8M | 1.53% | 19 |
|
|
2018
Q3 | $60M | Hold |
3,933,489
| – | – | 3.21% | 11 |
|
|
2018
Q2 | $48.2M | Hold |
3,933,489
| – | – | 3.13% | 13 |
|
|
2018
Q1 | $37.6M | Sell |
3,933,489
-1,032,024
| -21% | -$9.87M | 2.88% | 8 |
|
|
2017
Q4 | $44.8M | Buy |
4,965,513
+2,536,942
| +104% | +$22.9M | 3.75% | 8 |
|
|
2017
Q3 | $14M | Hold |
2,428,571
| – | – | 1.26% | 19 |
|
|
2017
Q2 | $7.7M | Hold |
2,428,571
| – | – | 0.88% | 19 |
|
|
2017
Q1 | $8.26M | Hold |
2,428,571
| – | – | 1.01% | 19 |
|
|
2016
Q4 | $6.99M | Hold |
2,428,571
| – | – | 0.99% | 16 |
|
|
2016
Q3 | $14.3M | Hold |
2,428,571
| – | – | 1.47% | 16 |
|
|
2016
Q2 | $7.29M | Hold |
2,428,571
| – | – | 1.01% | 20 |
|
|
2016
Q1 | $13M | Hold |
2,428,571
| – | – | 1.66% | 19 |
|
|
2015
Q4 | $28.8M | Hold |
2,428,571
| – | – | 2.85% | 12 |
|
|
2015
Q3 | $19.9M | Hold |
2,428,571
| – | – | 2.86% | 13 |
|
|
2015
Q2 | $33.9M | Hold |
2,428,571
| – | – | 3.41% | 8 |
|
|
2015
Q1 | $58.4M | Hold |
2,428,571
| – | – | 5.8% | 5 |
|
|
2014
Q4 | $40M | Hold |
2,428,571
| – | – | 4.3% | 7 |
|
|
2014
Q3 | $30.9M | Hold |
2,428,571
| – | – | 3.65% | 6 |
|
|
2014
Q2 | $54.8M | Hold |
2,428,571
| – | – | 5.54% | 4 |
|
|
2014
Q1 | $68.6M | Buy |
+2,428,571
| New | +$68.6M | 4.92% | 3 |
|